Physical Activity Linked to Better Survival for Specific Cancer Types

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, May 30, 2025 -- Engaging in leisure-time moderate- to vigorous-intensity physical activity (MVPA) is associated with better overall survival for participants with a history of various cancers, according to a study published online May 21 in the Journal of the National Cancer Institute.

Erika Rees-Punia, Ph.D., from the American Cancer Society in Atlanta, and colleagues examined relationships between postdiagnosis MVPA and all-cause mortality in participants with a history of 11 cancer types using data from six U.S.-based cohort studies.

The cohort included 90,844 cancer survivors, of whom 45,477 died during a follow-up of 10.9 years. The researchers found that engaging in recommended amounts of MVPA (7.5 to <15 metabolic equivalent hours per week) was related to better overall survival compared with no MVPA for participants with a history of one of 10 cancer types (hazard ratios, 0.44 for oral; 0.50 for endometrial; 0.51 for lung; 0.51 for rectal; 0.51 for respiratory; 0.53 for bladder; 0.53 for kidney; 0.60 for prostate; 0.61 for colon; and 0.67 for breast). When excluding participants who died within two years of follow-up, inverse associations remained similar for eight of the 10 cancers.

"This evidence for improved survival associated with physical activity behaviors postdiagnosis may be empowering for people living with and beyond cancer and may motivate health care providers, exercise professionals, and other clinicians to better equip themselves to promote physical activity to cancer patients as a routine standard of care," the authors write.

Abstract/Full Text (subscription or payment may be required

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-31 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords